CR20160562A - Péptidos como agonistas de la oxitocina - Google Patents

Péptidos como agonistas de la oxitocina

Info

Publication number
CR20160562A
CR20160562A CR20160562A CR20160562A CR20160562A CR 20160562 A CR20160562 A CR 20160562A CR 20160562 A CR20160562 A CR 20160562A CR 20160562 A CR20160562 A CR 20160562A CR 20160562 A CR20160562 A CR 20160562A
Authority
CR
Costa Rica
Prior art keywords
oxychocine
agonists
peptides
lower alkyl
cycloalkyl
Prior art date
Application number
CR20160562A
Other languages
English (en)
Inventor
Goutam Saha
Caterina Bissantz
Christophe Grundschober
Konrad Bleicher
Kanchan Chakraborty
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CR20160562A publication Critical patent/CR20160562A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La invención se refiere a compuestos de fórmula en donde R1 es hidrógeno, alquilo inferior, -CH2-cicloalquilo o cicloalquilo; R2 es hidrógeno, alquilo inferior, alquilo inferior sustituido con hidroxi, o R1 y R2 pueden formar junto con el átomo de N y C al que están unidos un anillo de pirrolidina opcionalmente sustituido con uno o dos átomos de F o con hidroxi, o puede formar una azetidina o un anillo de piperidina;
CR20160562A 2014-06-06 2014-06-06 Péptidos como agonistas de la oxitocina CR20160562A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14171440 2014-06-06
PCT/EP2015/062314 WO2015185584A1 (en) 2014-06-06 2015-06-03 Peptides as oxytocin agonists

Publications (1)

Publication Number Publication Date
CR20160562A true CR20160562A (es) 2017-01-06

Family

ID=50932985

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20160562A CR20160562A (es) 2014-06-06 2014-06-06 Péptidos como agonistas de la oxitocina

Country Status (16)

Country Link
US (1) US20170081368A1 (es)
EP (1) EP3152225B1 (es)
JP (1) JP6535688B2 (es)
KR (1) KR20170004014A (es)
CN (1) CN106459156A (es)
AU (1) AU2015270564A1 (es)
CA (1) CA2950493A1 (es)
CL (1) CL2016003076A1 (es)
CR (1) CR20160562A (es)
EA (1) EA030296B1 (es)
IL (1) IL248625A0 (es)
MX (1) MX2016015877A (es)
PE (1) PE20170427A1 (es)
PH (1) PH12016502251A1 (es)
SG (1) SG11201610221WA (es)
WO (1) WO2015185584A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20240166T1 (hr) 2014-09-19 2024-04-26 Ferring B.V. Postupak liječenja prader-willijevog sindroma
PT3665183T (pt) 2017-08-11 2025-03-10 Ferring Bv Método de preparação de uma composição farmacêutica
US20190135859A1 (en) 2017-08-11 2019-05-09 Ferring B.V. Method of manufacturing a pharmaceutical composition
KR20210062638A (ko) 2018-09-20 2021-05-31 레보 테라퓨틱스 인코포레이티드 카르베토신의 안정한 비강내 제형
AU2019345313A1 (en) 2018-09-20 2021-03-18 Levo Therapeutics, Inc. Carbetocin drug product and process for preparing same
CN113801200B (zh) * 2021-09-28 2023-07-25 浙江湃肽生物有限公司 一种卡贝缩宫素的制备方法
WO2024044633A2 (en) * 2022-08-23 2024-02-29 Seattle Children's Hospital (D/B/A Seattle Children's Research Institute) Oxytocin derivatives and methods of use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4483794A (en) * 1983-05-10 1984-11-20 Ceskoslovenska Akademie Ved Analogs of neurohypophysial hormones
KR20070022753A (ko) * 2004-05-26 2007-02-27 화이자 인코포레이티드 인다졸 및 인돌론 유도체 및 이의 약제로서의 용도
FR2875499B1 (fr) * 2004-09-20 2006-10-27 Sanofi Aventis Sa Nouveaux derives pyridiniques d'indolin-2-one, leur preparation et leur application en therapeutique
EA026578B1 (ru) * 2007-01-22 2017-04-28 ДЖиТиЭкс, ИНК. Вещества, связывающие ядерные рецепторы
DK2260053T3 (da) * 2008-03-31 2014-06-23 Ferring Bv Oxytocin-analoger
BRPI0919342A2 (pt) * 2008-09-23 2015-12-29 Hoffmann La Roche derivados do isoxazol [4,5] piridin-3-il-piperazina, seu processo de preparação, seu medicamento e seu uso
EP2427458B1 (en) * 2009-05-05 2014-05-07 F.Hoffmann-La Roche Ag Isoxazole-pyridazine derivatives
TWI463990B (zh) * 2009-09-21 2014-12-11 Ferring Bv 催產素受體促進劑
US9119805B2 (en) * 2009-10-01 2015-09-01 The University Of Sydney Therapy and prevention of problem drinking
WO2012016229A2 (en) 2010-07-30 2012-02-02 The Regents Of The University Of California Oxytocin treatment to improve memory and modify blood glucose

Also Published As

Publication number Publication date
US20170081368A1 (en) 2017-03-23
EA030296B1 (ru) 2018-07-31
SG11201610221WA (en) 2017-01-27
CL2016003076A1 (es) 2017-08-11
JP2017518313A (ja) 2017-07-06
CN106459156A (zh) 2017-02-22
KR20170004014A (ko) 2017-01-10
PH12016502251A1 (en) 2017-02-06
EP3152225B1 (en) 2018-11-14
EA201692488A1 (ru) 2017-05-31
MX2016015877A (es) 2017-03-27
IL248625A0 (en) 2017-01-31
AU2015270564A1 (en) 2016-11-17
EP3152225A1 (en) 2017-04-12
JP6535688B2 (ja) 2019-06-26
WO2015185584A1 (en) 2015-12-10
CA2950493A1 (en) 2015-12-10
PE20170427A1 (es) 2017-04-26

Similar Documents

Publication Publication Date Title
CR20160562A (es) Péptidos como agonistas de la oxitocina
ECSP17073191A (es) Compuestos heterocíclicos como inhibidores de lsd1
DOP2016000242A (es) Uso de compuestos heterocíclicos para controlar nematodos
MX2018003130A (es) Compuestos de heteroarilo como inhibidores de cinasas asociadas a receptor de interleucina-1 (irak) y usos de los mismos.
BR112016029333A2 (pt) síntese de compostos de carbamoilpiridona policíclico
UY34825A (es) Síntesis de compuestos heterocíclicos
HUE047895T2 (hu) Mikroszómális prosztaglandin E2 szintáz-1 gátlására alkalmas új metil-piperidin vegyületek
DOP2016000144A (es) Moduladores de tetrahidropiridopirazinas de gpr6
GT201200230A (es) Inhibidores del virus de la hepatitis c
BR112015027432B8 (pt) 3-(4-isobutil-2-metilfenil)propanal como ingrediente de perfume
MX2016015641A (es) Compuesto de pirrolidina novedoso, y aplicación como agonista del receptor de melanocortina.
EA201591634A1 (ru) Дигидропиридопиримидиновые соединения
CR20150271A (es) Peptidos como agonistas de oxitocina
UY35305A (es) Compuestos sustituidos como moduladores de la pro teína de activación de la 5-lipoxigenasa (flap)
CR20160198A (es) Derivados de etinilo-imidazolidín-2, 4-diona como moduladore mglur4
CR20160448A (es) Nuevos derivados de piridina
CR20140564A (es) Derivados de pirimidinona como agentes antimaláricos
AR103317A1 (es) Moduladores de ciclopropil dihidrobenzofurano de receptores de melatonina
CR20150417A (es) Compuestos de azetidiniloxifenilpirrolidina
ES2572052T3 (es) Amidas macrocíclicas como inhibidores de proteasas
JOP20200030B1 (ar) مركب خماسي الحلقة
CY1121116T1 (el) Νεα μεθοδος για την συνθεση αγομελατινης
PE20161559A1 (es) Peptidos como agonistas de la oxitocina
CR20160142A (es) Pirido [4,3-b]pirazín-2-carboxamidas como agentes neurogénicos para el tratamiento de trastornos neurodegenerativos
EA201790428A1 (ru) Синтез энт-прогестерона и его промежуточных соединений